The Presence Of Drug-Resistant Staph Reduces The Survival Of Patients

The Presence Of Drug-Resistant Staph Reduces The Survival Of Patients.
Cystic fibrosis patients with methicillin-resistant staphylococcus aureus (MRSA) in their respiratory region have worse survival rates than those without the drug-resistant bacteria, researchers have found. The redesigned study, published in the June 16 topic of the Journal of the American Medical Association, included 19,833 cystic fibrosis patients, old 6 to 45, who were enrolled in the writing-room from January 1996 to December 2006 and followed-up until December 2008.

During the mug up period, 2,537 of the patients died and 5,759 had MRSA detected in their respiratory tract. The expiry rate was 27,7 per 1000 patient-years middle those with MRSA and 18,3 deaths per 1000 patient-years for those without MRSA.